GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share …
3 days ago · GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of …
OFF
GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …
2 weeks from now
3 days ago · GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of …
investopedia.com
OFF
GSK Launches $2.5 Billion Buyback, Lifts Sales Target After Stellar ...
2 weeks from now
3 days ago · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and …
reuters.com
OFF
GSK Lifts Long-Term Outlook On Drug Pipeline, Buys Back Shares
2 weeks from now
3 days ago · (Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.Most Read from …
yahoo.com
OFF
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …
2 weeks from now
3 days ago · GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion Vandana Singh Wed, Feb 5, …
yahoo.com
OFF
GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook …
2 weeks from now
3 days ago · GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. ... New medicines the company plans to launch …
morningstar.com
OFF
GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After …
2 weeks from now
3 days ago · GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. ... on the back of expected new medicines between …
morningstar.com
OFF
GSK Raises Long-term Guidance, Announces Buybacks - MSN
2 weeks from now
GSK shares added ~6% in London trading on Wednesday after the British drugmaker lifted its 2031 outlook and announced a new share buyback program alongside better-than-expected …
msn.com
OFF
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 ... - Benzinga
2 weeks from now
3 days ago · GSK's Q4 sales hit $10.40 billion, topping estimates. Specialty Medicines grew 14%, while vaccines declined. The company announced a $2.5 billion share buyback plan.
benzinga.com
OFF
GSK Announces £2 Billion Share Buyback As Profit Beats Estimates
2 weeks from now
3 days ago · GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.
bloomberg.com
OFF
GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook
2 weeks from now
3 days ago · Health. Topics. Healthcare. Pharma. Wellness. ... GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook ... Listen (2 min) GSK expects sales to grow in 2025. …
wsj.com
OFF
GSK Launches £2bn Buyback On Strong HIV And Cancer Drugs Sales
2 weeks from now
3 days ago · GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of speciality medicines including cancer and HIV drugs, sending shares up as …
ft.com
OFF
GSK Launches $2.5 Bln Buyback, Lifts Sales Target After Stellar Q4
2 weeks from now
3 days ago · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and …
indiatimes.com
OFF
GSK: Enters 2025 In Good Health, Launches £2bn Buyback
2 weeks from now
3 days ago · A £2bn share buyback programme has also been launched. GSK expects top line growth of 3-5% this year and an uplift in underlying operating profit of 6-8%. The shares were …
hl.co.uk
OFF
GSK Launches £2bn Share Buyback And Upgrades Sales Forecast
2 weeks from now
3 days ago · Strong growth in HIV, oncology and specialty medicines have offset a 4 per cent decline in vaccine sales
thetimes.com
OFF
GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After …
2 weeks from now
3 days ago · The British pharmaceutical giant said Wednesday that the 2.0 billion-pound share buyback will be implemented over the next 18 months. The company said it now expects sales …
marketscreener.com
OFF
GSK Launches $2.5 Billion Buyback, Lifts Sales Target After ... - MSN
2 weeks from now
By Yadarisa Shabong (Reuters) -GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales …
msn.com
FAQs about GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share … Coupon?
Will GSK buy back £2 billion?
Will GSK increase its sales?
Why did GSK boost its 2031 sales forecast?
How much will GSK revenue increase in 2025?
Why did GSK shares rise 6% in London?
What was GSK's fourth-quarter sales?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
